Price Alert

ImmuCell Corporation (ICCC)

NASDAQ: ICCC · Real-Time Price · USD

5.92

-0.21 (-3.43%)

At close: Sep 12, 2025, 3:59 PM

5.89

-0.51%

After-hours: Sep 12, 2025, 06:13 PM EDT

ImmuCell Statistics

Share Statistics

ImmuCell has 9.05M shares outstanding. The number of shares has increased by 15.37% in one year.

Shares Outstanding	9.05M
Shares Change (YoY)	15.37%
Shares Change (QoQ)	1.41%
Owned by Institutions (%)	13.46%
Shares Floating	5.83M
Failed to Deliver (FTD) Shares	718
FTD / Avg. Volume	3.37%

Short Selling Information

The latest short interest is 13.62K, so 0.15% of the outstanding shares have been sold short.

Short Interest	13.62K
Short % of Shares Out	0.15%
Short % of Float	0.18%
Short Ratio (days to cover)	1.37

Valuation Ratios

The PE ratio is -19.5 and the forward PE ratio is -56.55. ImmuCell's PEG ratio is 0.3.

PE Ratio	-19.5
Forward PE	-56.55
PS Ratio	1.59
Forward PS	2.8
PB Ratio	1.53
P/FCF Ratio	-390.09
PEG Ratio	0.3

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for ImmuCell.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.41, with a Debt / Equity ratio of 0.55.

Current Ratio	3.41
Quick Ratio	1.8
Debt / Equity	0.55
Debt / EBITDA	13.61
Debt / FCF	-140.04
Interest Coverage	-2.88

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$383.96K
Profits Per Employee	$-31.26K
Employee Count	69
Asset Turnover	0.59
Inventory Turnover	2.61

Taxes

Income Tax	10.06K
Effective Tax Rate	-0.47%

Stock Price Statistics

The stock price has increased by 63.09% in the last 52 weeks. The beta is 0.3, so ImmuCell's price volatility has been higher than the market average.

Beta	0.3
52-Week Price Change	63.09%
50-Day Moving Average	6.4
200-Day Moving Average	5.59
Relative Strength Index (RSI)	45.96
Average Volume (20 Days)	21,324

Income Statement

In the last 12 months, ImmuCell had revenue of 26.49M and earned -2.16M in profits. Earnings per share was -0.26.

Revenue	26.49M
Gross Profit	7.94M
Operating Income	-1.64M
Net Income	-2.16M
EBITDA	1.11M
EBIT	-1.58M
Earnings Per Share (EPS)	-0.26

Full Income Statement

Balance Sheet

The company has 3.76M in cash and 15.1M in debt, giving a net cash position of -11.34M.

Cash & Cash Equivalents	3.76M
Total Debt	15.1M
Net Cash	-11.34M
Retained Earnings	-14.16M
Total Assets	46.72M
Working Capital	12.69M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 357.9K and capital expenditures -465.73K, giving a free cash flow of -107.82K.

Operating Cash Flow	357.9K
Capital Expenditures	-465.73K
Free Cash Flow	-107.82K
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is 29.97%, with operating and profit margins of -6.19% and -8.14%.

Gross Margin	29.97%
Operating Margin	-6.19%
Pretax Margin	-8.1%
Profit Margin	-8.14%
EBITDA Margin	4.19%
EBIT Margin	-6.19%
FCF Margin	-0.41%

Dividends & Yields

ICCC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for ICCC.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on Jul 25, 1990. It was a backward split with a ratio of 1:100.

Last Split Date	Jul 25, 1990
Split Type	backward
Split Ratio	1:100

Scores

Altman Z-Score	175.29
Piotroski F-Score	8